Overview

Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)

Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how well subjects respond to treatment with Rituximab plus Beta-Glucan.
Phase:
Phase 2
Details
Lead Sponsor:
James Graham Brown Cancer Center
University of Louisville
Collaborators:
James Graham Brown Cancer Center
University of Louisville
Treatments:
Rituximab